newsfilter
← Latest News
PR Newswire·

Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) today announced that it has received formal notification from The...